Skip to main content
Livermore
Livermore
ZHEN

Perceptive Advisors LLC

SEC CIK
0001224962
Latest filing
Aug 14, 2026

Holdings in Q1 2022

Holdings as of Mar 31, 2022, filed May 16, 2022. Long positions only; changes compare share counts with Q4 2021.

Institution overview
Positions
135
−10 vs. Q4 2021
Portfolio value
$4.81B
−$1.66B (−25.6%) vs. Q4 2021
Filed
May 16, 2022
SEC
Holdings of Perceptive Advisors LLC in Q1 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
Surrozen, Inc.86889P117*W EXP 08/01/203166,666$42.0K<0.1%00.0%Unchanged–
CareMax, Inc.14171W111*W EXP 06/08/20260,000$114.0K<0.1%00.0%Unchanged–
EQRx, Inc.26886C115*W EXP 12/17/202250,000$218.0K<0.1%00.0%Unchanged–
UTRSMinerva Surgical IncCOM50,268$226.0K<0.1%−37,500−42.7%ReducedHistory
SRZNSurrozen, Inc.COM77,723$234.0K<0.1%−335,723−81.2%ReducedHistory
SLGCWSomaLogic, Inc.*W EXP 03/01/202110,000$235.0K<0.1%00.0%UnchangedHistory
Butterfly Network, Inc.124155110*W EXP 05/27/202233,333$238.0K<0.1%00.0%Unchanged–
Rockley Photonics Holdings LG7614L117*W EXP 08/11/202500,000$425.0K<0.1%00.0%Unchanged–
NEPTFNeptune Wellness Solutions Inc.COM2,000,000$445.0K<0.1%−8,055,521−80.1%ReducedHistory
MOTSMotus GI Holdings, Inc.COM1,800,542$648.0K<0.1%00.0%UnchangedHistory
RPIDRapid Micro Biosystems, Inc.CLASS A COM190,745$1.29M<0.1%−194,948−50.5%ReducedHistory
ONCROncorus, Inc.COM752,241$1.34M<0.1%−247,571−24.8%ReducedHistory
RACEFerrari N.V.COM6,200$1.35M<0.1%00.0%UnchangedHistory
RETAReata Pharmaceuticals IncCL A44,475$1.46M<0.1%+44,475NewHistory
LENZLENZ Therapeutics, Inc.COM325,854$1.66M<0.1%−524,239−61.7%ReducedHistory
DRIODarioHealth Corp.COM NEW327,869$1.92M<0.1%00.0%UnchangedHistory
TARAProtara Therapeutics, Inc.COM STK383,526$1.96M<0.1%−38,115−9.0%ReducedHistory
ABOSAcumen Pharmaceuticals, Inc.COM596,942$2.33M<0.1%+596,942NewHistory
PRTAProthena Corp Public Ltd CoSHS65,144$2.38M<0.1%−34,856−34.9%ReducedHistory
ZYZymergen Inc.COM883,332$2.55M0.1%00.0%UnchangedHistory
SONXSonendo, Inc.COM668,505$2.68M0.1%00.0%UnchangedHistory
RVNCRevance Therapeutics, Inc.COM137,514$2.68M0.1%+137,514NewHistory
NARIInari Medical, Inc.Stock30,000$2.72M0.1%+30,000NewHistory
RLMDRelmada Therapeutics, Inc.COM151,350$4.08M0.1%+151,350NewHistory
IMRXImmuneering CorpCLASS A COM681,051$4.41M0.1%00.0%UnchangedHistory
NVTAInvitae CorpCOM554,585$4.42M0.1%−1,030,000−65.0%ReducedHistory
OBIOOrchestra BioMed Holdings, Inc.ORD SHS450,000$4.46M0.1%00.0%UnchangedHistory
SGHTSight Sciences, Inc.COM390,000$4.51M0.1%00.0%UnchangedHistory
PEARPear Therapeutics, Inc.CLASS A COM926,232$4.68M0.1%00.0%UnchangedHistory
DALSDA32 Life Science Tech Acquisition Corp.CLASS A COM500,000$4.86M0.1%00.0%UnchangedHistory
NVNOenVVeno Medical CorpCOMMON STOCK781,615$4.98M0.1%00.0%UnchangedHistory
TYRATyra Biosciences, Inc.COM494,403$5.29M0.1%−178,949−26.6%ReducedHistory
HYPRHyperfine, Inc.COM CL A1,500,000$5.31M0.1%00.0%UnchangedHistory
CLOVClover Health Investments, Corp.COM CL A1,500,000$5.33M0.1%00.0%UnchangedHistory
DAWNDay One Biopharmaceuticals, Inc.Stock556,047$5.52M0.1%00.0%UnchangedHistory
MRUSMerus N.V.COM209,046$5.53M0.1%−140,954−40.3%ReducedHistory
PRVAPrivia Health Group, Inc.COM213,423$5.71M0.1%+213,423NewHistory
PRVBProvention Bio, Inc.COM791,549$5.79M0.1%−156,932−16.5%ReducedHistory
ACCDAccolade, Inc.COM330,682$5.81M0.1%+101,908+44.5%AddedHistory
PYXSPyxis Oncology, Inc.COMMON STOCK1,528,812$6.18M0.1%−415,302−21.4%ReducedHistory
ACRSAclaris Therapeutics, Inc.COM383,239$6.61M0.1%−397,997−50.9%ReducedHistory
ACADAcadia Pharmaceuticals IncCOM284,853$6.90M0.1%−1,299,199−82.0%ReducedHistory
FULCFulcrum Therapeutics, Inc.COM294,118$6.96M0.1%00.0%UnchangedHistory
CNCEConcert Pharmaceuticals, Inc.COM2,150,641$7.25M0.2%00.0%UnchangedHistory
WGSGeneDx Holdings Corp.COMMON STOCK2,500,000$7.67M0.2%00.0%UnchangedHistory
NBTXNanobiotix S.A.SPONSORED ADS1,059,800$7.88M0.2%00.0%UnchangedHistory
SNCEScience 37 Holdings, Inc.COM1,500,000$8.03M0.2%00.0%UnchangedHistory
EVHEvolent Health, Inc.CL A250,000$8.07M0.2%+250,000NewHistory
ATXSAstria Therapeutics, Inc.COM1,281,197$8.60M0.2%00.0%UnchangedHistory
NUVBNuvation Bio Inc.COM CL A1,769,701$9.31M0.2%−1,151,122−39.4%ReducedHistory
PNTPOINT Biopharma Global Inc.COM1,193,995$9.52M0.2%00.0%UnchangedHistory
FUSNFusion Pharmaceuticals Inc.COM1,227,017$9.53M0.2%00.0%UnchangedHistory
ICVXIcosavax, Inc.COM1,379,137$9.71M0.2%−527,411−27.7%ReducedHistory
RACBResearch Alliance Corp. IICOM CL A1,000,000$9.76M0.2%00.0%UnchangedHistory
Summit Healthcre Acquistn CoG8566R128UNIT 06/03/20261,000,000$9.78M0.2%00.0%Unchanged–
BCLS Acquisition CorpG0904B105COM CL A1,000,000$9.87M0.2%00.0%Unchanged–
ABSIAbsci CorpCOM1,190,952$10.0M0.2%−220,824−15.6%ReducedHistory
HLTHCue Health Inc.COM1,580,607$10.2M0.2%00.0%UnchangedHistory
Nanostring Technologies Inc63009RAD1NOTE 2.625% 5/0–$11.0M0.2%–––
ATNXAthenex, Inc.COM13,532,467$11.2M0.2%00.0%UnchangedHistory
SLGCSomaLogic, Inc.CLASS A COM1,500,000$12.0M0.2%00.0%UnchangedHistory
Rain Oncology Inc.75082Q105COM2,483,619$12.6M0.3%00.0%Unchanged–
RCUSArcus Biosciences, Inc.COM405,000$12.8M0.3%+405,000NewHistory
HCATHealth Catalyst, Inc.COM493,662$12.9M0.3%+39,658+8.7%AddedHistory
LYRALyra Therapeutics, Inc.COM3,222,560$13.0M0.3%00.0%UnchangedHistory
AORTArtivion, Inc.COM615,703$13.2M0.3%+289,385+88.7%AddedHistory
LUNGPulmonx CorpCOM537,779$13.3M0.3%−224,525−29.5%ReducedHistory
MGNXMacrogenics IncCOM1,559,789$13.7M0.3%−105,454−6.3%ReducedHistory
CYPHCypherpunk Technologies Inc.COM7,951,448$13.9M0.3%−525,048−6.2%ReducedHistory
ISOIsoPlexis CorpCOM4,095,498$14.0M0.3%00.0%UnchangedHistory
VRNAVerona Pharma plcSPONSORED ADS3,044,303$15.2M0.3%+176,793+6.2%AddedHistory
SLDBSolid Biosciences Inc.COM13,412,552$16.1M0.3%00.0%UnchangedHistory
KRONKronos Bio, Inc.COM2,421,142$17.5M0.4%00.0%UnchangedHistory
TMCITreace Medical Concepts, Inc.COM971,192$18.4M0.4%−8,994−0.9%ReducedHistory
AMLXAmylyx Pharmaceuticals, Inc.COM1,474,107$18.9M0.4%+1,474,107NewHistory
QTNTQuotient LtdSHS16,200,818$19.4M0.4%00.0%UnchangedHistory
IMTXImmatics N.V.SHS2,500,000$20.0M0.4%00.0%UnchangedHistory
VERUVeru Inc.COM4,361,998$21.1M0.4%−89,344−2.0%ReducedHistory
AXNXAxonics, Inc.COM341,211$21.4M0.4%+341,211NewHistory
TARSTarsus Pharmaceuticals, Inc.COM1,296,416$21.8M0.5%00.0%UnchangedHistory
ADMAAdma Biologics, Inc.COM11,933,387$21.8M0.5%00.0%UnchangedHistory
LABPLandos Biopharma, Inc.COM14,869,915$21.9M0.5%00.0%UnchangedHistory
LEGNLegend Biotech CorpSPONSORED ADS616,141$22.4M0.5%+427,041+225.8%AddedHistory
OMICSingular Genomics Systems, Inc.COM3,655,207$23.1M0.5%+321,383+9.6%AddedHistory
ZNTLZentalis Pharmaceuticals, Inc.COM501,509$23.1M0.5%+70,965+16.5%AddedHistory
CMAXCareMax, Inc.COM CL A3,186,663$23.8M0.5%−362,862−10.2%ReducedHistory
COGTCogent Biosciences, Inc.COM3,188,750$23.9M0.5%00.0%UnchangedHistory
NUVLNuvalent, Inc.COM1,751,601$24.3M0.5%+1,001,601+133.5%AddedHistory
VRDNViridian Therapeutics, Inc.COM1,423,053$26.3M0.5%00.0%UnchangedHistory
RCKTRocket Pharmaceuticals, Inc.COM1,678,090$26.6M0.6%−281,035−14.3%ReducedHistory
MDGLMadrigal Pharmaceuticals, Inc.COM278,286$27.3M0.6%+191,886+222.1%AddedHistory
DICEDICE Therapeutics, Inc.COM1,515,361$29.0M0.6%+810,476+115.0%AddedHistory
VRCAVerrica Pharmaceuticals Inc.COM3,610,412$29.3M0.6%00.0%UnchangedHistory
ALNYAlnylam Pharmaceuticals, Inc.COM180,079$29.4M0.6%+180,079NewHistory
ESTAEstablishment Labs Holdings Inc.COM450,374$30.4M0.6%+44,833+11.1%AddedHistory
MORFMorphic Holding, Inc.COM767,327$30.8M0.6%−69,194−8.3%ReducedHistory
PENPenumbra IncCOM143,591$31.9M0.7%+143,591NewHistory
NVRONevro CorpCOM477,037$34.5M0.7%+454,091+1,979.0%AddedHistory
ZYMEZymeworks Inc.COM5,325,615$34.9M0.7%+1,645,770+44.7%AddedHistory
NBIXNeurocrine Biosciences IncStock395,639$37.1M0.8%−87,368−18.1%ReducedHistory

Sold out since Q4 2021 (24)

Positions held at the end of Q4 2021 that are gone from this filing.

Positions of Perceptive Advisors LLC sold out since Q4 2021
SecurityClassShares in Q4 2021Value in Q4 2021% of portfolio in Q4 2021History
Retrophin Inc761299AB2NOTE 2.500% 9/1–$484.7M7.5%–
BMRNBiomarin Pharmaceutical IncCOM1,180,000$104.3M1.6%History
Nevro Corp64157FAC7NOTE 2.750% 4/0–$101.5M1.6%–
ARNAArena Pharmaceuticals IncCOM NEW500,000$46.5M0.7%History
KODKodiak Sciences Inc.COM520,152$44.1M0.7%History
UTHRUnited Therapeutics CorpCOM94,064$20.3M0.3%History
VTRSViatris IncStock1,004,419$13.6M0.2%History
BCABBioAtla, Inc.COM661,200$13.0M0.2%History
IMCRImmunocore Holdings plcADS360,000$12.3M0.2%History
BIIBBiogen Inc.COM48,600$11.7M0.2%History
HRMYHarmony Biosciences Holdings, Inc.COM239,258$10.2M0.2%History
ADPTAdaptive Biotechnologies CorpCOM352,804$9.90M0.2%History
KYMRKymera Therapeutics, Inc.COM155,000$9.84M0.2%History
ONEM1Life Healthcare IncCOM532,350$9.35M0.1%History
CLDXCelldex Therapeutics, Inc.COM NEW229,807$8.88M0.1%History
EQRXEQRx, Inc.COM1,250,000$8.53M0.1%History
TBIOTelesis Bio Inc.COM425,000$4.59M0.1%History
Achilles Therapeutics PLC00449L102SPONSORED ADS755,375$3.78M0.1%–
AXSMAxsome Therapeutics, Inc.COM80,420$3.04M<0.1%History
PMVPPMV Pharmaceuticals, Inc.COM125,000$2.89M<0.1%History
YARWYarrow Bioscience, Inc.COM2,178,022$2.22M<0.1%History
ITOSiTeos Therapeutics, Inc.COM20,000$931.0K<0.1%History
EIGREiger BioPharmaceuticals, Inc.COM139,890$726.0K<0.1%History
PHVSPharvaris N.V.COM27,000$389.0K<0.1%History